Paper · 40380331
The biological activity and potential of probiotics-derived extracellular vesicles as postbiotics in modulating microbiota-host communication.
Zhang X and 6 others. J Nanobiotechnology, 2025. Cited by 32 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. The biological activity and potential of probiotics-derived extracellular vesicles as postbiotics in modulating microbiota-host communication. Papers, record 40380331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40380331
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The biological activity and potential of probiotics-derived extracellular vesicles as postbiotics in modulating microbiota-host communication.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Probiotics | Major topic |
| Extracellular Vesicles | Major topic |
| Gastrointestinal Microbiome | Major topic |
| Microbiota | Major topic |
| Host Microbial Interactions | Major topic |
| Humans | |
| Animals | |
| Lactobacillus | |
| Bifidobacterium |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| No. 32371335 | the National Natural Science Foundation of China | PubMed | ||
| Grant No. 2023-MS-260 | the Natural Science Foundation of Liaoning Province | PubMed |
Source PubMed
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References176
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34,925,349 | Effect of Extracellular Vesicles Derived From Lactobacillus plantarum Q7 on Gut Microbiota and Ulcerative Colitis in Mice. | Front Immunol | 2021 | https://conductscience.org/library/papers/34925349 | PubMed |
| 2 | 27,892,954 | A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice. | Nat Med | 2017 | https://conductscience.org/library/papers/27892954 | PubMed |
| 3 | 31,731,390 | Detection and Quantification of eDNA-Associated Bacterial Membrane Vesicles by Flow Cytometry. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/31731390 | PubMed |
| 4 | 35,344,296 | Immunoregulatory effects of Lactococcus lactis-derived extracellular vesicles in allergic asthma. | Clin Transl Allergy | 2022 | https://conductscience.org/library/papers/35344296 | PubMed |
| 5 | 37,563,797 | Mass-produced gram-negative bacterial outer membrane vesicles activate cancer antigen-specific stem-like CD8+ T cells which enables an effective combination immunotherapy with anti-PD-1. | J Extracell Vesicles | 2023 | https://conductscience.org/library/papers/37563797 | PubMed |
| 6 | 28,634,130 | The inhibitory impacts of Lactobacillus rhamnosus GG-derived extracellular vesicles on the growth of hepatic cancer cells. | Microb Pathog | 2017 | https://conductscience.org/library/papers/28634130 | PubMed |
| 7 | 21,876,150 | Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. | Proc Natl Acad Sci U S A | 2011 | https://conductscience.org/library/papers/21876150 | PubMed |
| 8 | 36,174,995 | Bifidobacterium longum and Galactooligosaccharide Improve Skin Barrier Dysfunction and Atopic Dermatitis-like Skin. | Allergy Asthma Immunol Res | 2022 | https://conductscience.org/library/papers/36174995 | PubMed |
| 9 | 31,148,560 | Vaginal lactobacilli inhibit growth and hyphae formation of Candida albicans. | Sci Rep | 2019 | https://conductscience.org/library/papers/31148560 | PubMed |
| 10 | 33,123,130 | Inhibitory Effects of the Lactobacillus rhamnosus GG Effector Protein HM0539 on Inflammatory Response Through the TLR4/MyD88/NF-кB Axis. | Front Immunol | 2020 | https://conductscience.org/library/papers/33123130 | PubMed |
1 to 10 of 176
See all 176 referencesCited by31
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 32 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,908,011 | Decoding metabolic diseases through bacterial extracellular vesicles: mechanisms, diagnostics, and therapeutics. | J Nanobiotechnology | 2026 | https://conductscience.org/library/papers/42908011 | PubMed |
| 42,908,001 | Lactobacillus mucosae extracellular vesicles improve metabolic dysfunction-associated fatty liver disease by activating the AMPK pathway via the gut-liver axis. | J Nanobiotechnology | 2026 | https://conductscience.org/library/papers/42908001 | PubMed |
| 42,891,232 | Lactobacillus derived small RNAs protect against Klebsiella pneumoniae infection. | Imeta | 2026 | https://conductscience.org/library/papers/42891232 | PubMed |
| 42,828,074 | Bacterial extracellular vesicles as central mediators of microbiota-host communication. | Front Microbiol | 2026 | https://conductscience.org/library/papers/42828074 | PubMed |
| 42,792,211 | Probiotics and Extracellular Vesicles as Redox Modulators in Wound Healing: From Microbial Therapeutics to Engineered Nanotherapeutic Strategies. | Antioxidants (Basel) | 2026 | https://conductscience.org/library/papers/42792211 | PubMed |
| 42,746,344 | Beyond the Pancreas: The Gut Microbiota in Acute Pancreatitis - From Mechanisms to Therapeutic Perspectives. | Clin Exp Gastroenterol | 2026 | https://conductscience.org/library/papers/42746344 | PubMed |
| 42,712,961 | Probiotic-Derived Extracellular Vesicles as Potential Nano-Immunotherapeutic Platforms in IBD: A Clinician's Perspective. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42712961 | PubMed |
| 42,643,951 | Lactobacillus rhamnosus GG-Derived Extracellular Vesicles Accumulated Lung Tissue to Attenuate Sepsis-Induced Acute Lung Injury by Suppressing Inflammation and Restoring Barrier Integrity. | J Inflamm Res | 2026 | https://conductscience.org/library/papers/42643951 | PubMed |
| 42,514,994 | Extracellular Vesicles from Kluyveromyces marxianus as Potential Postbiotics Against Candida albicans Vaginal Infections. | Pathogens | 2026 | https://conductscience.org/library/papers/42514994 | PubMed |
| 42,491,287 | Tryptophan-Enriched Lactobacillus rhamnosus GG-derived Nanovesicles Promote Alveolar Bone Regeneration through Macrophage Fatty Acid Oxidation. | Biomater Res | 2026 | https://conductscience.org/library/papers/42491287 | PubMed |
1 to 10 of 31
See all 31 cited byGenes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40380331
GET https://conductscience.org/api/papers/v1/40380331/references?page=2